nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS2—type 2 diabetes mellitus	0.275	1	CbGaD
Lornoxicam—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0739	0.114	CbGbCtD
Lornoxicam—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0739	0.114	CbGbCtD
Lornoxicam—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0682	0.105	CbGbCtD
Lornoxicam—PTGS1—Nateglinide—type 2 diabetes mellitus	0.056	0.0861	CbGbCtD
Lornoxicam—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0537	0.0826	CbGbCtD
Lornoxicam—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0411	0.0633	CbGbCtD
Lornoxicam—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0376	0.0579	CbGbCtD
Lornoxicam—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.035	0.0538	CbGbCtD
Lornoxicam—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0297	0.0457	CbGbCtD
Lornoxicam—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0297	0.0457	CbGbCtD
Lornoxicam—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0274	0.0422	CbGbCtD
Lornoxicam—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0265	0.0408	CbGbCtD
Lornoxicam—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0242	0.0373	CbGbCtD
Lornoxicam—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0225	0.0347	CbGbCtD
Lornoxicam—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0216	0.0332	CbGbCtD
Lornoxicam—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0152	0.0234	CbGbCtD
Lornoxicam—CYP2C9—Losartan—type 2 diabetes mellitus	0.0139	0.0214	CbGbCtD
Lornoxicam—PTGS2—leg—type 2 diabetes mellitus	0.00145	0.167	CbGeAlD
Lornoxicam—PTGS2—hindlimb—type 2 diabetes mellitus	0.0013	0.149	CbGeAlD
Lornoxicam—PTGS1—artery—type 2 diabetes mellitus	0.000833	0.0956	CbGeAlD
Lornoxicam—PTGS2—artery—type 2 diabetes mellitus	0.000796	0.0914	CbGeAlD
Lornoxicam—Tenoxicam—PTGS2—type 2 diabetes mellitus	0.000769	0.277	CrCbGaD
Lornoxicam—PTGS1—endothelium—type 2 diabetes mellitus	0.000704	0.0808	CbGeAlD
Lornoxicam—PTGS2—endothelium—type 2 diabetes mellitus	0.000673	0.0772	CbGeAlD
Lornoxicam—Meloxicam—CYP3A4—type 2 diabetes mellitus	0.000559	0.202	CrCbGaD
Lornoxicam—Meloxicam—PTGS2—type 2 diabetes mellitus	0.000548	0.197	CrCbGaD
Lornoxicam—Piroxicam—PTGS2—type 2 diabetes mellitus	0.000475	0.171	CrCbGaD
Lornoxicam—Piroxicam—ALB—type 2 diabetes mellitus	0.000423	0.153	CrCbGaD
Lornoxicam—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000383	0.0439	CbGeAlD
Lornoxicam—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000317	0.0364	CbGeAlD
Lornoxicam—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.00029	0.0332	CbGeAlD
Lornoxicam—PTGS1—kidney—type 2 diabetes mellitus	0.000283	0.0325	CbGeAlD
Lornoxicam—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000277	0.0318	CbGeAlD
Lornoxicam—PTGS2—kidney—type 2 diabetes mellitus	0.000271	0.0311	CbGeAlD
Lornoxicam—PTGS2—pancreas—type 2 diabetes mellitus	0.000269	0.0309	CbGeAlD
Lornoxicam—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000255	0.0293	CbGeAlD
Lornoxicam—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000244	0.028	CbGeAlD
Lornoxicam—CYP2C9—liver—type 2 diabetes mellitus	0.000196	0.0225	CbGeAlD
Lornoxicam—PTGS2—liver—type 2 diabetes mellitus	0.000171	0.0196	CbGeAlD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.48e-05	0.000395	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.47e-05	0.000393	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RBP4—type 2 diabetes mellitus	2.43e-05	0.000386	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	2.43e-05	0.000386	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	2.43e-05	0.000386	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.42e-05	0.000385	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.42e-05	0.000385	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.42e-05	0.000385	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.39e-05	0.00038	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.37e-05	0.000377	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	2.36e-05	0.000376	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.36e-05	0.000375	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.35e-05	0.000374	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	2.35e-05	0.000373	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.35e-05	0.000373	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	2.35e-05	0.000373	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	2.35e-05	0.000373	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	2.35e-05	0.000373	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MTR—type 2 diabetes mellitus	2.34e-05	0.000373	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CPT1A—type 2 diabetes mellitus	2.34e-05	0.000373	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.31e-05	0.000367	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NAMPT—type 2 diabetes mellitus	2.3e-05	0.000365	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.28e-05	0.000363	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—LIPC—type 2 diabetes mellitus	2.28e-05	0.000363	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—HBA1—type 2 diabetes mellitus	2.28e-05	0.000363	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GCK—type 2 diabetes mellitus	2.28e-05	0.000363	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	2.28e-05	0.000363	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	2.28e-05	0.000363	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	2.28e-05	0.000363	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	2.28e-05	0.000363	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	2.27e-05	0.000361	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.27e-05	0.000361	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	2.27e-05	0.000361	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.23e-05	0.000354	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTR—type 2 diabetes mellitus	2.22e-05	0.000353	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CETP—type 2 diabetes mellitus	2.2e-05	0.00035	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.19e-05	0.000349	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	2.19e-05	0.000348	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.19e-05	0.000348	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	2.18e-05	0.000346	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—GCK—type 2 diabetes mellitus	2.16e-05	0.000344	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IAPP—type 2 diabetes mellitus	2.15e-05	0.000342	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	2.15e-05	0.000341	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	2.15e-05	0.000341	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.13e-05	0.000338	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	2.11e-05	0.000336	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	2.09e-05	0.000332	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.08e-05	0.000331	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.06e-05	0.000327	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.05e-05	0.000327	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PSMD6—type 2 diabetes mellitus	2.05e-05	0.000326	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SNAP25—type 2 diabetes mellitus	2.05e-05	0.000326	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SREBF1—type 2 diabetes mellitus	2.05e-05	0.000326	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	2.03e-05	0.000323	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CTGF—type 2 diabetes mellitus	2.01e-05	0.00032	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	1.99e-05	0.000317	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	1.99e-05	0.000317	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	1.99e-05	0.000317	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—HMGCR—type 2 diabetes mellitus	1.99e-05	0.000317	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	1.98e-05	0.000315	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.97e-05	0.000312	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.95e-05	0.00031	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	1.94e-05	0.000309	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	1.94e-05	0.000309	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.91e-05	0.000304	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.91e-05	0.000304	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.9e-05	0.000302	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CYBA—type 2 diabetes mellitus	1.88e-05	0.000299	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.87e-05	0.000298	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	1.86e-05	0.000296	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	1.86e-05	0.000296	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.85e-05	0.000295	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.85e-05	0.000295	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.84e-05	0.000293	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.84e-05	0.000293	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	1.82e-05	0.00029	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CALCA—type 2 diabetes mellitus	1.82e-05	0.000289	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.81e-05	0.000288	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	1.81e-05	0.000288	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	1.81e-05	0.000288	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	1.81e-05	0.000288	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.81e-05	0.000287	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.81e-05	0.000287	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.81e-05	0.000287	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.8e-05	0.000287	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.8e-05	0.000286	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.78e-05	0.000283	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.78e-05	0.000283	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.78e-05	0.000283	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	1.78e-05	0.000282	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.78e-05	0.000282	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.77e-05	0.000281	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	1.76e-05	0.000279	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	1.75e-05	0.000278	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOS1—type 2 diabetes mellitus	1.73e-05	0.000275	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.72e-05	0.000274	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.72e-05	0.000273	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	1.71e-05	0.000272	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	1.68e-05	0.000268	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.67e-05	0.000266	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.65e-05	0.000262	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.63e-05	0.000259	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	1.63e-05	0.000259	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	1.63e-05	0.000259	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	1.63e-05	0.000259	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.61e-05	0.000255	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	1.6e-05	0.000254	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	1.58e-05	0.000252	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.56e-05	0.000249	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.56e-05	0.000249	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.56e-05	0.000248	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.55e-05	0.000246	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	1.53e-05	0.000243	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.53e-05	0.000243	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	1.52e-05	0.000242	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.51e-05	0.00024	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.51e-05	0.00024	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.51e-05	0.00024	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.51e-05	0.00024	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	1.5e-05	0.000239	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.49e-05	0.000236	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	1.47e-05	0.000234	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.47e-05	0.000234	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	1.46e-05	0.000233	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	1.46e-05	0.000232	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.45e-05	0.000231	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	1.45e-05	0.00023	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.43e-05	0.000228	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	1.42e-05	0.000226	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	1.42e-05	0.000226	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	1.41e-05	0.000224	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.41e-05	0.000224	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.41e-05	0.000224	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	1.39e-05	0.000222	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—APOB—type 2 diabetes mellitus	1.38e-05	0.00022	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.38e-05	0.000219	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	1.36e-05	0.000217	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.36e-05	0.000217	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	1.36e-05	0.000216	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.35e-05	0.000214	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	1.32e-05	0.000211	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—LPL—type 2 diabetes mellitus	1.32e-05	0.00021	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.31e-05	0.000208	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	1.29e-05	0.000206	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.26e-05	0.0002	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	1.25e-05	0.0002	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	1.24e-05	0.000197	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.23e-05	0.000196	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.23e-05	0.000196	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	1.23e-05	0.000196	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CCR5—type 2 diabetes mellitus	1.22e-05	0.000194	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.22e-05	0.000193	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	1.22e-05	0.000193	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	1.21e-05	0.000192	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.21e-05	0.000192	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.2e-05	0.000191	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.2e-05	0.000191	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.2e-05	0.000191	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.2e-05	0.000191	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	1.19e-05	0.00019	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.19e-05	0.00019	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	1.19e-05	0.00019	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	1.19e-05	0.000189	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	1.17e-05	0.000186	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.17e-05	0.000186	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	1.17e-05	0.000186	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	1.16e-05	0.000184	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.16e-05	0.000184	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	1.15e-05	0.000184	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	1.13e-05	0.00018	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IRS2—type 2 diabetes mellitus	1.13e-05	0.00018	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	1.13e-05	0.000179	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CALM1—type 2 diabetes mellitus	1.11e-05	0.000177	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—APOE—type 2 diabetes mellitus	1.11e-05	0.000176	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	1.11e-05	0.000176	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—APOA1—type 2 diabetes mellitus	1.09e-05	0.000174	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	1.08e-05	0.000172	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.08e-05	0.000172	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	1.08e-05	0.000172	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.08e-05	0.000171	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.08e-05	0.000171	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.08e-05	0.000171	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.06e-05	0.000168	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	1.05e-05	0.000167	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.05e-05	0.000167	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.04e-05	0.000165	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.03e-05	0.000164	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOS2—type 2 diabetes mellitus	1.03e-05	0.000164	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.03e-05	0.000163	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	1.02e-05	0.000162	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—INS—type 2 diabetes mellitus	9.98e-06	0.000159	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	9.96e-06	0.000158	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IRS1—type 2 diabetes mellitus	9.88e-06	0.000157	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	9.85e-06	0.000157	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	9.77e-06	0.000155	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	9.74e-06	0.000155	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	9.74e-06	0.000155	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	9.5e-06	0.000151	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	9.47e-06	0.000151	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—INS—type 2 diabetes mellitus	9.46e-06	0.00015	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.45e-06	0.00015	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	9.34e-06	0.000148	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	9.34e-06	0.000148	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	9.31e-06	0.000148	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	9.27e-06	0.000147	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	9.17e-06	0.000146	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	9.15e-06	0.000145	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKT2—type 2 diabetes mellitus	9.14e-06	0.000145	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.75e-06	0.000139	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	8.75e-06	0.000139	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	8.69e-06	0.000138	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	8.3e-06	0.000132	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOS3—type 2 diabetes mellitus	8.3e-06	0.000132	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	8.08e-06	0.000128	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	8.05e-06	0.000128	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.05e-06	0.000128	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	8.01e-06	0.000127	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	8.01e-06	0.000127	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—INS—type 2 diabetes mellitus	7.92e-06	0.000126	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	7.9e-06	0.000126	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	7.67e-06	0.000122	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	7.46e-06	0.000119	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	7.33e-06	0.000117	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	7.26e-06	0.000115	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	7.17e-06	0.000114	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	7.15e-06	0.000114	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	6.96e-06	0.000111	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.95e-06	0.00011	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	6.95e-06	0.00011	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	6.87e-06	0.000109	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	6.6e-06	0.000105	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	6.47e-06	0.000103	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	6.27e-06	9.97e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	6.16e-06	9.8e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	6.14e-06	9.77e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SRC—type 2 diabetes mellitus	6.14e-06	9.76e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	6.07e-06	9.65e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	5.49e-06	8.72e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EGFR—type 2 diabetes mellitus	5.38e-06	8.55e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	5.35e-06	8.51e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.25e-06	8.34e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	4.81e-06	7.65e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	4.6e-06	7.32e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	4.6e-06	7.32e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.21e-06	6.69e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6—type 2 diabetes mellitus	4.13e-06	6.57e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	4.02e-06	6.4e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKT1—type 2 diabetes mellitus	3.81e-06	6.06e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	3.19e-06	5.08e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.12e-06	3.36e-05	CbGpPWpGaD
